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Diagnosis of extrapulmonary tuberculosis (TB) is often challenging. In this work we discuss the utility
of an assay for Lipoarabinomannan (LAM) antibody detection in synovial fluid. LAM is one of the three major
groups of lipopolysaccharides within the Mycobacterium tuberculosis (MTB) cell wall. An ELISA based test was used to
investigate the presence of antibodies against LAM in an immunocompetent patient with knee arthritis. The symptoms
resolved after isoniazid treatment. LAM positivity has been used as a diagnostic tool for TB in different settings,
including veterinary field. The test could be of some value to diagnose tuberculous arthritis in selected patients when
gold standard test returned negative although further investigations are welcome.
Keywords: Arthritis; Mycobacteria; ELISA; LipoarabinomannanTuberculosis (TB) remains one of the leading infectious
cause of mortality world-wide. Musculoskeletal manifes-
tations account for 10% of extrapulmonary tuberculosis
and include tuberculous arthritis.
A 48-year-old otherwise healthy man presented with a
3-month long history of oligoarthritis (left hip and knees)
preceded by three weeks of mild night sweats. Personal
history was not informative, with the exception of a recent
travel in a TB endemic area. General physical examination
was unremarkable.
Intensive rheumatological work-up, including serology,
complete joint imaging, chest X-rays and comprehensive
synovial-fluid analysis was inconclusive. A diagnosis of
undifferentiated arthritis was considered and two courses
of intra articular steroid injection along with non steroidal
antiinflammatory drugs were undertaken with only short
relief.
Therefore, in the view of the recent history of TB con-
tact and of IFN-gamma release assay positivity (19 U,
cut off at 0.35 U) extensive search for M. tuberculosis on
multiple biological specimens was performed: micros-
copy, polymerase chain reaction (PCR) and cultures of
sputum, urine, synovial fluid and synovial tissue returned* Correspondence: sechila@uniss.it
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in any medium, provided the original work is pall negative. On the contrary, an intense positivity for
anti-lipoarabinomannan (LAM) antibodies IgG (Erre
et al. 2014) in synovial fluid, but not in peripheral blood
was demonstrated.
A presumptive diagnosis of tuberculous arthritis was
then considered and an expectancy therapy with a 6-
month short course of isoniazide was started. Arthritis
gradually improved in 6 months and after 10 months the
end of treatment the patient is fully recovered.
TB diagnosis largely rely on clinical suspicion, smear
staining, liquid culture for M. tuberculosis and nucleic
acid amplification tests. The International Standards for
TB Care strongly discourages the use of serological tests
in routine practice for the diagnosis of pulmonary and
extrapulmonary TB (Hopewell et al. 2006).
However, extrapulmonary TB may represent a diag-
nostic dilemma due to the relative insensitivity of smear,
PCR and cultures of body fluid or tissues (Valdes et al.
1998). In TB arthritis synovial fluid smear staining is
positive in only 20–40% of cases (Mahowald 2000) and
21% of the synovial fluid cultures have been reported to
be negative (Malaviya & Kotwal 2003).
The accuracy of a commercial kit testing antibodies
to LAM, a lipoglycan of the mycobacterial cell wall, has
been recently tested showing a good discrimination
power between TB and non-TB subjects (Malaviya &n Open Access article distributed under the terms of the Creative Commons
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has been reported to be of utility in diagnosing pul-
monary and extrapulmonary TB (Dhana et al. 2014;
Yokoyama et al. 2005; Lawn et al. 2014; Bua et al. 2009).
In our case, the diagnosis of tuberculous arthritis
could be established on the basis of patient history (in-
cluding recent exposure to M. tuberculosis contacts),
absence of an alternative clear diagnosis, positivity for
anti-LAM antibodies on synovial fluid and complete re-
covery after anti-tuberculous chemotherapy.
Negativity of anti-LAM antibodies in peripheral
blood, further strengthened the hypothesis of a true M.
tuberculosis localization in the joint triggering anti-
LAM antibodies production restricted to the synovial
microenvironment.
The analysis of our case suggests that, anti-LAM test-
ing could be of some value to diagnose tuberculous
arthritis in selected patients when gold standard test
returned negative. However, further investigations are
required in the matter, before anti-LAM antibodies
testing could be recommended as a routine TB diag-
nostic test.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
GP, GE, PP and LAS conceived the study. GE and LAS drafted the
manuscript. PP and LAS carried out the tests. All authors read and
approved the final manuscript.
Acknowledgments
This investigation was supported by grants from: the Sardinian Region L.R.7
2010 Progetti di ricerca di base CRP-25160, and the Fondazione Banco di
Sardegna year 2014-0184.
Author details
1Dipartimento di Medicina Clinica e Sperimentale, Università di Sassari,
Sassari, Italy. 2Unità di Pneumologia, Università di Sassari, Sassari, Italy.
3Dipartimento di Scienze Biomediche, Università di Sassari, Sassari, Italy.
Received: 26 January 2015 Accepted: 27 January 2015
References
Bua A, Rosu V, Molicotti P, Das Gupta SK, Ahmed N, Zanetti S, Sechi LA (2009)
Phages specific for mycobacterial lipoarabinomannan help serodiagnosis of
tuberculosis. New Microbiol 32:293–296
Dhana AV, Howell P, Spencer D (2014) When smear and molecular diagnostics
fail: identification of tuberculosis in advanced HIV infection using the newly
developed urine lipoarabinomannan lateral-flow assay. BMJ Case Rep 10:2014
Erre GL, Cossu D, Masala S, Mameli G, Cadoni ML, Serdino S, Longu MG, Passiu G,
Sechi LA (2014) Mycobacterium tuberculosis lipoarabinomannan antibodies
are associated to rheumatoid arthritis in Sardinian patients. Clin Rheumatol
33:1725–1729
Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC (2006) International
standards for tuberculosis care. Lancet Infect Dis 6:710–725
Lawn SD, Kerkhoff AD, Burton R, Meintjes G (2014) Underestimation of the
incremental diagnostic yield of HIV-associated tuberculosis in studies of the
Determine TB-LAM Ag urine assay. AIDS 28:1846–1848
Mahowald ML (2000) Arthritis Due To Mycobacteria, Fungi and Parasites. In:
Koopman WJ (ed) Arthritis and Allied Conditions, 14th edn, on-line version,
chapter 128. Lippincott Williams & Wilkins, PhiladelphiaMalaviya AN, Kotwal PP (2003) Arthritis associated with tuberculosis. Best Pract
Res Clin Rheumatol 17:319–343
Valdes L, Alvarez D, San Jose E, Penela P, Valle JM, Garcia-Pazos JM, Suárez J, Pose
A (1998) Tuberculous pleurisy. a study of 254 patients. Arch Intern Med
158:2017–2021
Yokoyama T, Rikimaru T, Kinoshita T, Kamimura T, Oshita Y, Aizawa H (2005)
Clinical utility of lipoarabinomannan antibody in pleural fluid for the
diagnosis of tuberculous pleurisy. J Infect Chemother 11:81–83Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
